# MODEL_RELEASE_APPROVAL_WORKFLOW.md  
**AI Model Release, Validation & Authorization Workflow**

---

## 1. Purpose

This document defines the **mandatory release approval workflow** for all AI models deployed within the NeuroGrid ecosystem, including models used for Remote Patient Monitoring (RPM), post-operative care, and bio-cybernetic systems.

The workflow ensures that **no AI model enters production without formal validation, governance approval, and regulatory readiness**.

---

## 2. Core Principle

> **No model is deployed by default.  
Every model must earn release authorization.**

Automation does not replace accountability.

---

## 3. Scope

This workflow applies to:
- New AI model deployments
- Updated or retrained models
- Threshold or logic modifications
- RPM alert models
- Bio-cybernetic inference systems
- Emergency patches and overrides

---

## 4. Release Stages Overview

All models must pass **six gated stages** before release:

1. Development Completion  
2. Technical Validation  
3. Clinical Safety Review  
4. Compliance & Ethics Approval  
5. Governance Authorization  
6. Production Release & Logging  

Skipping stages is prohibited.

---

## 5. Stage 1 – Development Completion

**Objective:** Confirm technical readiness

Requirements:
- Version identifier assigned
- Training data lineage documented
- Model architecture frozen
- Reproducible build artifacts generated
- Model card completed

Output:
- Development Completion Certificate (internal)

---

## 6. Stage 2 – Technical Validation

**Objective:** Verify functional correctness

Validation includes:
- Performance benchmarking
- Stress and edge-case testing
- Drift simulation
- False positive / false negative analysis
- Latency and reliability checks

Failure Criteria:
- Unstable outputs
- Inconsistent inference behavior
- Unacceptable performance variance

---

## 7. Stage 3 – Clinical Safety Review

**Objective:** Confirm clinical appropriateness

Required actions:
- Review by qualified clinical experts
- Evaluation of alert thresholds
- Assessment of potential patient harm
- RPM escalation pathway validation

Clinical veto authority is absolute.

---

## 8. Stage 4 – Compliance & Ethics Approval

**Objective:** Ensure regulatory and ethical alignment

Review includes:
- GDPR / LGPD / HIPAA compliance
- MDR / FDA SaMD alignment
- Consent boundary validation
- Ethics framework consistency
- Bio-cybernetic risk assessment

Any unresolved compliance issue blocks release.

---

## 9. Stage 5 – Governance Authorization

**Objective:** Formal release approval

Authorization requires:
- DAO or governance body vote
- Approval quorum met
- Conflict-of-interest check
- Decision immutably logged

Emergency releases follow separate override protocol.

---

## 10. Stage 6 – Production Release & Logging

**Objective:** Controlled deployment

Actions:
- Release timestamp recorded
- Version hash registered
- Monitoring hooks activated
- Post-market monitoring enabled
- Audit trail finalized

Release without logging is invalid.

---

## 11. Emergency Release Pathway

Emergency releases are permitted only when:
- Patient safety is at risk
- Delay increases harm probability
- Emergency governance powers are invoked

Emergency releases must:
- Be time-limited
- Trigger immediate post-release review
- Be fully documented

---

## 12. Human Oversight Requirement

At no stage may:
- A model self-approve release
- Automation bypass governance
- Deployment occur without accountable sign-off

Human authority is mandatory.

---

## 13. Release Rejection Handling

If a model is rejected:
- Reasons must be documented
- Corrective actions defined
- Re-submission follows full workflow
- No partial approvals allowed

---

## 14. DeSci Considerations

For decentralized models:
- Approval authority remains centralized
- Contributors cannot self-authorize releases
- Token incentives do not influence approval outcomes

Decentralization does not dilute responsibility.

---

## 15. Audit & Traceability

Every release must be traceable to:
- Review artifacts
- Approvers
- Decision timestamps
- Model version and configuration

Audit gaps constitute non-compliance.

---

## 16. Enforcement

Violations may result in:
- Model suspension
- Governance sanctions
- Emergency shutdown
- Regulatory escalation

---

## 17. Binding Status

This workflow is:
- Mandatory
- Enforceable
- Non-optional
- Subject to periodic review only through governance vote

---

### Status
**Active – Model Release Approval Workflow**

